ARTICLE 1Escrow Agreement • September 6th, 2000 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 6th, 2000 Company Industry Jurisdiction
EXHIBIT 4.2 NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE...Nastech Pharmaceutical Co Inc • November 2nd, 2001 • Pharmaceutical preparations
Company FiledNovember 2nd, 2001 Industry
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2023 • Adhera Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 29th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of ______________, by and between Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).
Exhibit 10.2 STOCK OPTION AGREEMENT (this "Agreement") dated as of January 30, 2006 (the "Grant Date"), between Nastech Pharmaceutical Company Inc., a Delaware corporation (the "Company"), and Timothy M. Duffy ("Grantee"), an employee of the Company....Stock Option Agreement • February 3rd, 2006 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 3rd, 2006 Company Industry Jurisdiction
RECITALSLease • August 2nd, 2006 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations
Contract Type FiledAugust 2nd, 2006 Company Industry
EMPLOYMENT AGREEMENT AGREEMENT, dated this 1st day of September, 1997 between Nastech Pharmaceutical Company Inc., a Delaware corporation (the "Company") with offices at 45 Davids Drive, Hauppauge, NY and Vincent D. Romeo, Ph.D. (the "Executive"). W I...Employment Agreement • March 31st, 1998 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 31st, 1998 Company Industry Jurisdiction
BETWEENAsset Purchase Agreement • July 1st, 2003 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 1st, 2003 Company Industry Jurisdiction
Nastech Pharmaceutical Company Inc. 1,725,000 Shares Common Stock ($0.006 par value)Nastech Pharmaceutical Co Inc • August 30th, 2005 • Pharmaceutical preparations • New York
Company FiledAugust 30th, 2005 Industry Jurisdiction
EXHIBIT 10.1 LOAN AGREEMENTLoan Agreement • October 15th, 2002 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 15th, 2002 Company Industry Jurisdiction
EXHIBIT 10.1 SUPPLY AGREEMENTSupply Agreement • June 8th, 2006 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 8th, 2006 Company Industry Jurisdiction
EXHIBIT 2.4 NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE...Nastech Pharmaceutical Co Inc • September 6th, 2000 • Pharmaceutical preparations
Company FiledSeptember 6th, 2000 Industry
Exhibit 10.23 ADDENDUM TO SECURITY AGREEMENT: SECURITIES ACCOUNT THIS ADDENDUM is attached to and made a part of that certain Security Agreement: Securities Account executed by NASTECH PHARMACEUTICAL COMPANY INC. ("Debtor") in favor of WELLS FARGO...Security Agreement • March 15th, 2004 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations
Contract Type FiledMarch 15th, 2004 Company Industry
1) 2 3. Incentive Compensation. The Executive shall also be entitled to annual incentive compensation of up to fifty (50)% of the applicable base salary if the Company's business objectives as set forth in the Company's annual business plan are...Employment Agreement • March 31st, 1998 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 31st, 1998 Company Industry Jurisdiction
EXHIBIT 10.2 STOCK OPTION AGREEMENT (this "Agreement") dated as of October 5th, 2005 (the "Grant Date"), between Nastech Pharmaceutical Company Inc., a Delaware corporation (the "Company"), and Mr. Paul H. Johnson, Ph.D. (Grantee"), an employee of the...Stock Option Agreement • October 7th, 2005 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 7th, 2005 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 12th, 2021 • Adhera Therapeutics, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledNovember 12th, 2021 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 7, 2021, by and between ADHERA THERAPEUTICS INC, a Delaware corporation, with headquarters located at 8000 Innovation Parkway, Baton Rouge, LA 70820 (the “Company”) and BLUE LAKE PARTNERS, LLC, a Delaware limited liability company, with its address at 3411 Silverside Road, Tatnal Building #104, Wilmington, DE 19810 (the “Buyer”).
RECITALSPurchase Agreement • September 4th, 2003 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 4th, 2003 Company Industry Jurisdiction
COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC.Common Stock Purchase Warrant • August 10th, 2015 • Marina Biotech, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 10th, 2015 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________________________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date and on or prior to the six (6) year anniversary of the Issuance Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from Marina Biotech, Inc., a Delaware corporation (the “Company”), up to ________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 20th, 2012 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 20th, 2012 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 19, 2012 between Marina Biotech, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 17th, 2011 • Marina Biotech, Inc. • Pharmaceutical preparations • Illinois
Contract Type FiledOctober 17th, 2011 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 11, 2011, by and between MARINA BIOTECH, INC., a Delaware corporation, (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
SENIOR SECURED original issue discount Convertible PROMISSORY NOTEAdhera Therapeutics, Inc. • April 23rd, 2021 • Pharmaceutical preparations • New York
Company FiledApril 23rd, 2021 Industry JurisdictionTHIS SENIOR SECURED ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE is a duly authorized and validly issued Senior Secured Original Issue Discount Convertible Promissory Note issued at a 10% original issue discount by Adhera Therapeutics, Inc., a Delaware corporation (the “Company”) (this “Note”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 30th, 2008 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 30th, 2008 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 25, 2008, between Nastech Pharmaceutical Company Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
1 EXHIBIT 10.21 EMPLOYMENT AGREEMENT AGREEMENT, dated this 27th day of December, 1999 between Nastech Pharmaceutical Company Inc., a Delaware corporation ("Employer") with offices at 45 Davids Drive, Hauppauge, NY and Andrew P. Zinzi ("Employee"). W I...Employment Agreement • March 30th, 2000 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2000 Company Industry Jurisdiction
WITNESSETH:Employment Agreement • March 30th, 1999 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 1999 Company Industry Jurisdiction
ARTICLE I DEFINITIONSSecurity Agreement • October 15th, 2002 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 15th, 2002 Company Industry Jurisdiction
SECURITY AGREEMENTSecurity Agreement • June 29th, 2023 • Adhera Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJune 29th, 2023 Company IndustryThis SECURITY AGREEMENT, dated as of _______________ (this “Agreement”), is among Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), all of the subsidiaries of the Company (such subsidiaries, the “Guarantors” and together with the Company, the “Debtors”) and the holders of the Company’s Original Issue Discount Senior Secured Promissory Notes (collectively, the “Notes”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”).
2 August 2001 LICENSE AGREEMENT This Agreement is made and entered into this 2 day of August, 2001 (the "Effective Date"), by and between NASTECH PHARMACEUTICAL COMPANY INC., a corporation duly organized and existing under the laws of Delaware and...License Agreement • October 29th, 2001 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • London
Contract Type FiledOctober 29th, 2001 Company Industry Jurisdiction
1 EXHIBIT 10.19 INTERNATIONAL DISTRIBUTOR AGREEMENT EFFECTIVE DATE: ____________________________ PARTIES: Nastech Pharmaceuticals Inc., 45 Davids Drive Hauppauge New York 11788 USA Fax no: 00 1 516 273 0252 ("Company") Cambridge Selfcare Diagnostics...Distributor Agreement • March 30th, 1999 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 1999 Company Industry Jurisdiction
AGREEMENTAgreement • November 15th, 2002 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • Ohio
Contract Type FiledNovember 15th, 2002 Company Industry Jurisdiction
MARINA BIOTECH, INC. [______] Units Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase Up To [___] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 7th, 2015 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 7th, 2015 Company Industry JurisdictionMarina Biotech, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters listed on Schedule I hereto (the “Underwriters”), for whom Roth Capital Partners, LLC and Ladenburg Thalmann & Co. Inc. are acting as representatives (the “Representatives”) an aggregate of (i) [____] authorized but unissued shares (the “Firm Shares”) of Common Stock, par value $0.006 per share (the “Common Stock”), of the Company and (ii) Warrants (the “Firm Warrants”) to purchase up to [____] shares of Common Stock (the “Firm Warrant Shares”). The Company has granted the Underwriters the option to purchase an aggregate of up to (i) __________ additional shares of Common Stock from the Company (the “Option Shares”) and (ii) Warrants (the “Option Warrants”) to purchase up to [____] additional shares of Common Stock (the “Option Warrant Shares” and together with the Firm Warrant Shares, the “Warrant Shares”), in each case as may
COMMON STOCK PURCHASE WARRANT marina biotech, inc.Common Stock Purchase • February 5th, 2013 • Marina Biotech, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 5th, 2013 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Marina Biotech, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 10.25 NASTECH PHARMACEUTICAL COMPANY INC. STAND-ALONE STOCK OPTION AGREEMENT I. NOTICE OF STOCK OPTION GRANT Gregory L. Weaver [Address] You have been granted a Nonstatutory Stock Option to purchase Common Stock of the Company, subject to the...Nastech Pharmaceutical Co Inc • March 28th, 2003 • Pharmaceutical preparations • Washington
Company FiledMarch 28th, 2003 Industry Jurisdiction
COMMON STOCK PURCHASE WARRANTAdhera Therapeutics, Inc. • June 29th, 2023 • Pharmaceutical preparations
Company FiledJune 29th, 2023 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, , or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fifth year six month anniversary (December 22, 2028) of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), up to 500,000 shares of Common Stock (subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant issued pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) entered into as of the Initial Exercise Date between the Company and the initial Holder.
Nastech Pharmaceutical Company Inc. 3,250,000 Shares Common Stock ($0.006 par value per Share) Underwriting AgreementUnderwriting Agreement • January 19th, 2007 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 19th, 2007 Company Industry JurisdictionEach of the undersigned, Steven C. Quay, Chairman of the Board, President and Chief Executive Officer of Nastech Pharmaceutical Company Inc., a Delaware corporation (the “Company”), and Philip C. Ranker, Chief Financial Officer and Secretary of the Company, on behalf of the Company, does hereby certify pursuant to Section 6(i) of that certain Underwriting Agreement dated January 17, 2007 (the “Underwriting Agreement”) between the Company and UBS Securities LLC, that as of [date]:
January 3, 2001 Nastech Pharmaceutical Company Inc. 45 Davids Drive Hauppauge, New York 11788 Attn: Andrew Zinzi Waiver of Section 2.1(f)(ii) of Equity Line of Credit Agreement Dear Mr. Zinzi: Reference is made to the Equity Line of Credit Agreement,...Nastech Pharmaceutical Co Inc • January 12th, 2001 • Pharmaceutical preparations
Company FiledJanuary 12th, 2001 IndustryReference is made to the Equity Line of Credit Agreement, dated as of July 11, 2000 (the "Agreement"), between Castlebar Enterprises Limited ("Castlebar") and Nastech Pharmaceutical Company Inc. ("Nastech"). Pursuant to Section 2.1(f)(ii) of the Agreement, on each date of settlement of a put, Nastech is obligated to issue to Castlebar a warrant to purchase up to a number of shares of common stock of Nastech ("Common Stock") equal to 25% of the number of shares of Common Stock purchased by the Castlebar on such date (defined both in the Agreement and herein as "Short Term Warrants").
WITNESSETHLicense and Supply Agreement • August 14th, 1997 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 14th, 1997 Company Industry Jurisdiction